Camp4 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	12.61	38.38	83.19
Cash & Short-Term Investments	12.61	38.38	83.19
Cash Growth	-	-53.86%	-
Other Receivables	0.35	0.44	0.68
Receivables	0.35	0.44	0.68
Prepaid Expenses	-	0.29	0.16
Other Current Assets	1.83	0.9	0.38
Total Current Assets	14.79	40.01	84.41
Property, Plant & Equipment	11.78	13.31	16.79
Other Long-Term Assets	1.62	1.62	1.35
Total Assets	29.94	54.95	102.55
Accounts Payable	1.46	1.04	2.15
Accrued Expenses	2.93	3.01	3.17
Current Portion of Long-Term Debt	0.29	0.41	-
Current Portion of Leases	3.1	3.06	2.37
Other Current Liabilities	-	0.29	0.26
Total Current Liabilities	7.79	7.81	7.95
Long-Term Debt	-	0.09	-
Long-Term Leases	7.12	8.64	10.03
Other Long-Term Liabilities	0	0	-0.04
Total Liabilities	14.91	16.53	17.93
Common Stock	0	0	0
Additional Paid-In Capital	37.88	36.23	33.14
Retained Earnings	-184.99	-159.96	-110.67
Total Common Equity	-147.11	-123.73	-77.53
Shareholders' Equity	15.03	38.42	84.62
Total Liabilities & Equity	29.94	54.95	102.55
Total Debt	10.52	12.18	12.4
Net Cash (Debt)	2.09	26.2	70.8
Net Cash Growth	-	-63.00%	-
Net Cash Per Share	4.69	66.33	226.69
Filing Date Shares Outstanding	0.49	0.46	0.31
Total Common Shares Outstanding	0.49	0.46	0.31
Working Capital	7	32.21	76.46
Book Value Per Share	-299.70	-268.57	-248.26
Tangible Book Value	-147.11	-123.73	-77.53
Tangible Book Value Per Share	-299.70	-268.57	-248.26
Machinery	4.95	4.78	4.17
Leasehold Improvements	4.52	4.52	4.52

Source: S&P Capital IQ. Standard template. Financial Sources.